Louis O’Dea
About
Louis O’Dea is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Molecular Biology.
According to data from OpenAlex, Louis O’Dea has authored 48 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Reproductive Medicine and 16 papers in Molecular Biology. Recurrent topics in Louis O’Dea's work include Ovarian function and disorders (18 papers), Hypothalamic control of reproductive hormones (13 papers) and Hormonal and reproductive studies (8 papers). Louis O’Dea is often cited by papers focused on Ovarian function and disorders (18 papers), Hypothalamic control of reproductive hormones (13 papers) and Hormonal and reproductive studies (8 papers). Louis O’Dea collaborates with scholars based in United States, Canada and Germany. Louis O’Dea's co-authors include Joseph L. Witztum, Sotirios Tsimikas, Joel S. Finkelstein, William F. Crowley, Randall W. Whitcomb, Richard S. Geary, Ewa Karwatowska‐Prokopczuk, Seth J. Baum, David Schoenfeld and Shuting Xia and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Blood.
In The Last Decade
Louis O’Dea
47 papers receiving 3.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Louis O’Dea United States | 25 | 1.2k | 1.1k | 975 | 806 | 704 | 48 | 3.1k | ||
| Kelly A. Volcik United States | 27 | 300 0.3× | 473 0.4× | 703 0.7× | 601 0.7× | 116 0.2× | 48 | 2.8k | ||
| Frédérique Savagner France | 24 | 793 0.7× | 183 0.2× | 260 0.3× | 1.0k 1.3× | 262 0.4× | 58 | 2.2k | ||
| Adina F. Turcu United States | 33 | 2.4k 2.0× | 1.0k 0.9× | 165 0.2× | 1.1k 1.4× | 312 0.4× | 117 | 3.1k | ||
| Laure Lecerf France | 23 | 1.7k 1.4× | 700 0.6× | 2.2k 2.2× | 752 0.9× | 107 0.2× | 43 | 3.5k | ||
| Steven J. Adelman United States | 24 | 459 0.4× | 840 0.8× | 348 0.4× | 540 0.7× | 56 0.1× | 33 | 2.3k | ||
| Masashi Demura Japan | 21 | 611 0.5× | 312 0.3× | 258 0.3× | 504 0.6× | 307 0.4× | 54 | 1.6k | ||
| Annabelle Rodríguez United States | 23 | 497 0.4× | 536 0.5× | 184 0.2× | 378 0.5× | 129 0.2× | 50 | 1.9k | ||
| Allen P. Yates United Kingdom | 25 | 503 0.4× | 624 0.6× | 536 0.5× | 477 0.6× | 754 1.1× | 51 | 2.4k | ||
| Markus Eszlinger Germany | 29 | 1.7k 1.4× | 541 0.5× | 211 0.2× | 957 1.2× | 137 0.2× | 97 | 3.3k | ||
| Ottavia Porzio Italy | 30 | 848 0.7× | 796 0.7× | 243 0.2× | 1.1k 1.3× | 53 0.1× | 97 | 2.6k |
Countries citing papers authored by Louis O’Dea
Since
Specialization
Citations
This map shows the geographic impact of Louis O’Dea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis O’Dea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis O’Dea more than expected).
Fields of papers citing papers by Louis O’Dea
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Louis O’Dea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis O’Dea. The network helps show where Louis O’Dea may publish in the future.
Co-authorship network of co-authors of Louis O’Dea
This figure shows the co-authorship network connecting the top 25 collaborators of Louis O’Dea. A scholar is included among the top collaborators of Louis O’Dea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis O’Dea. Louis O’Dea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Oral, Elif A, Abhimanyu Garg, Joseph A. Tami, et al.. (2022). Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study. Journal of clinical lipidology. 16(6). 833–849.
2.
Watts, Lynnetta M., Ewa Karwatowska‐Prokopczuk, Eunju Hurh, et al.. (2020). Treatment with Volanesorsen, a 2′-O-Methoxyethyl-Modified Antisense Oligonucleotide Targeting APOC3 mRNA, Does Not Affect the QTc Interval in Healthy Volunteers. Nucleic Acid Therapeutics. 30(4). 198–206.
3.
Gaudet, Daniel, Ewa Karwatowska‐Prokopczuk, Seth J. Baum, et al.. (2020). Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia. European Heart Journal. 41(40). 3936–3945.
4.
Khella, Sami, Morie A. Gertz, Teresa Coelho, et al.. (2020). Rationale and Design of NEURO-TTRansform, a Phase 3 Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx (ION-682884) in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy (2240). Neurology. 94(15_supplement).
5.
O’Dea, Louis, Joseph A. Tami, Veronica J. Alexander, et al.. (2020). Efficacy and safety of volanesorsen for the treatment of metabolic complications in patients with familial partial lipodystrophy: results of the BROADEN study. Endocrine Abstracts.
6.
O’Dea, Louis, James E. MacDougall, Veronica J. Alexander, et al.. (2019). Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical Profiles. Journal of the Endocrine Society. 3(12). 2397–2410.
7.
Alexander, Veronica J., Shuting Xia, Eunju Hurh, et al.. (2019). N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels. European Heart Journal. 40(33). 2785–2796.
8.
Arca, Marcello, Andrew Hsieh, Handrean Soran, et al.. (2018). The effect of volanesorsen treatment on the burden associated with familial chylomicronemia syndrome: the results of the ReFOCUS study. Expert Review of Cardiovascular Therapy. 16(7). 537–546.
9.
King, Thomas C., Mark J. Upfal, Edward J. Bernacki, et al.. (2015). T-SPOT. TB Interferon-γ Release Assay Performance in Healthcare Worker Screening at Nineteen U.S. Hospitals. American Journal of Respiratory and Critical Care Medicine. 192(3). 367–373.
10.
Leder, Benjamin Z., Louis O’Dea, José Zanchetta, et al.. (2014). Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 100(2). 697–706.
11.
Shoham, Zeev, et al.. (2008). Recombinant LH (lutropin alfa) for the treatment of hypogonadotrophic women with profound LH deficiency: a randomized, double‐blind, placebo‐controlled, proof‐of‐efficacy study. Clinical Endocrinology. 69(3). 471–478.
12.
Kaufmann, Robert A., R.C. Dunn, Graeme J. Hughes, et al.. (2007). Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin‐deficient women. Clinical Endocrinology. 67(4). 563–569.
13.
Loumaye, Ernest, Patrick Engrand, Colin M. Howles, & Louis O’Dea. (1998). Assessment of the Role of Serum Luteinizing Hormone and Estradiol Response to Follicle-Stimulating Hormone on In Vitro Fertilization Treatment Outcome. Fertility and Sterility. 69(3). 76S–85S.
14.
Banks, Kate, et al.. (1998). Recombinant follicle-stimulating hormone in a patient hypersensitive to urinary-derived gonadotropins. Gynecological Endocrinology. 12(3). 209–212.
15.
Loumaye, Ernest, Isabelle Martineau, Louis O’Dea, et al.. (1996). Clinical assessment of human gonadotrophins produced by recombinant DNA technology. Human Reproduction. 11(Supplement_5). 95–107.
16.
Crowley, William F., Randall W. Whitcomb, J. Larry Jameson, et al.. (1991). Neuroendocrine Control of Human Reproduction in the Male. Elsevier eBooks. 47. 27–67.
17.
Whitcomb, Randall W., et al.. (1990). Utility of Freeα-Subunit as an Alternative Neuroendocrine Marker of Gonadotropin-Releasing Hormone (GnRH) Stimulation of the Gonadotroph in the Human: Evidence from Normal and GnRH-Deficient Men*. The Journal of Clinical Endocrinology & Metabolism. 70(6). 1654–1661.
18.
Lee, Peter A. & Louis O’Dea. (1990). Primary and Secondary Testicular Insufficiency. Pediatric Clinics of North America. 37(6). 1359–1387.
19.
Spratt, Daniel, Louis O’Dea, David Schoenfeld, et al.. (1988). Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. American Journal of Physiology-Endocrinology and Metabolism. 254(5). E658–E666.
20.
Finkelstein, Joel S., Thomas M. Badger, Louis O’Dea, Daniel Spratt, & W F Crowley. (1988). Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells.. Journal of Clinical Investigation. 81(6). 1725–1733.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kelly A. Volcik Breakdown of academic impact, for papers by Frédérique Savagner Breakdown of academic impact, for papers by Adina F. Turcu Breakdown of academic impact, for papers by Laure Lecerf Breakdown of academic impact, for papers by Steven J. Adelman Breakdown of academic impact, for papers by Masashi Demura Breakdown of academic impact, for papers by Annabelle Rodríguez Breakdown of academic impact, for papers by Allen P. Yates Breakdown of academic impact, for papers by Markus Eszlinger Breakdown of academic impact, for papers by Ottavia Porzio